Amgen (AMGN)
NASDAQ:AMGN

Amgen (AMGN) Financial Statements

4,738 Followers

Amgen Financial Overview

Amgen's market cap is currently ―. The company's EPS TTM is $12.112; its P/E ratio is 19.69; and it has a dividend yield of 3.36%. Amgen is scheduled to report earnings on April 25, 2023, and the estimated EPS forecast is $4.00. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenue$ 6.84B$ 6.65B$ 6.59B$ 6.24B$ 6.85B
Gross Profit$ 5.09B$ 5.06B$ 5.08B$ 4.68B$ 5.13B
EBIT$ 2.16B$ 2.76B$ 1.86B$ 1.97B$ 2.47B
EBITDA$ 3.07B$ 3.60B$ 2.69B$ 2.81B$ 3.32B
Net Income Common Stockholders$ 1.62B$ 2.14B$ 1.32B$ 1.48B$ 1.90B
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 9.30B$ 11.48B$ 7.18B$ 6.54B$ 8.04B
Total Assets$ 65.12B$ 63.70B$ 59.29B$ 59.20B$ 61.16B
Total Debt$ 38.95B$ 38.70B$ 36.52B$ 36.85B$ 33.31B
Net Debt$ 29.64B$ 27.23B$ 29.34B$ 30.31B$ 25.27B
Total Liabilities$ 61.46B$ 60.05B$ 56.88B$ 58.28B$ 54.47B
Stockholders Equity$ 3.66B$ 3.65B$ 2.42B$ 916.00M$ 6.70B
Cash Flow-
Free Cash Flow$ 2.31B$ 2.82B$ 1.68B$ 1.97B$ 2.52B
Operating Cash Flow$ 2.65B$ 2.98B$ 1.93B$ 2.16B$ 2.81B
Investing Cash Flow$ -3.47B$ -267.00M$ -2.19B$ -111.00M$ -230.00M
Financing Cash Flow$ -1.05B$ 1.59B$ -1.06B$ -3.51B$ -6.56B
Currency in USD

Amgen Earnings and Revenue History


Amgen Debt to Assets


Amgen Cash Flow


Amgen Forecast EPS vs Actual EPS


What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis